Free Trial

NewAmsterdam Pharma (NAMSW) Institutional Ownership

NewAmsterdam Pharma logo
$27.31 -2.68 (-8.94%)
As of 05/14/2026 03:30 PM Eastern

Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMSW)

Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$385.47K
Number of
Institutional Sellers
(last 12 months)
0
Get NAMSW Insider Trade Alerts

Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NAMSW Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Aristeia Capital L.L.C.15,708$397K0.0%N/A0.000%
8/13/2025Affinity Asset Advisors LLC245,000$1.96M0.3%+1.3%0.000%
5/14/2025Affinity Asset Advisors LLC241,957$2.18M0.2%+1.7%0.000%
5/12/2025Wolverine Asset Management LLC8,884$80K0.0%-30.0%0.000%
2/13/2025Affinity Asset Advisors LLC237,935$3.33M0.4%+11.7%0.000%
2/3/2025Wolverine Asset Management LLC12,693$181K0.0%N/A0.000%
7/23/2024TFC Financial Management Inc.10,000$87K0.0%N/A0.000%
5/15/2024Affinity Asset Advisors LLC202,599$2.24M0.3%+47.9%0.000%
2/15/2024Clear Street LLC8,993$28K0.0%-33.2%0.000%
2/14/2024ADAR1 Capital Management LLC82,857$259K0.1%N/A0.000%
11/15/2023Affinity Asset Advisors LLC137,000$260K0.1%+270.3%0.000%
8/7/2023Wolverine Asset Management LLC12,448$26K0.0%N/A0.000%
5/15/2023Affinity Asset Advisors LLC37,000$68K0.0%N/A0.000%
5/12/2023Clear Street LLC17,619$32K0.0%N/A0.000%
5/11/2023Highbridge Capital Management LLC733,327$1.36M0.0%+4.0%0.000%
5/10/2023Exos TFP Holdings LLC93,932$173K0.0%-31.6%0.000%
2/14/2023RA Capital Management L.P.333,333$289K0.0%N/A0.000%
2/14/2023EcoR1 Capital LLC66,665$727K0.0%N/A0.000%
2/10/2023Exos TFP Holdings LLC137,317$119K0.0%N/A0.000%
2/3/2023Frazier Life Sciences Management L.P.500,333$434K0.0%N/A0.000%


NAMSW Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of NewAmsterdam Pharma shares: Affinity Asset Advisors LLC ($1.96M), Aristeia Capital L.L.C. ($397K), and TFC Financial Management Inc. ($87K), Wolverine Asset Management LLC ($80K).Learn more on NewAmsterdam Pharma's institutional investors.

The following institutional investors have purchased NewAmsterdam Pharma's stock in the last 24 months: Affinity Asset Advisors LLC ($97.63K), Aristeia Capital L.L.C. ($15.71K), Wolverine Asset Management LLC ($12.69K), and TFC Financial Management Inc. ($10K).

Institutional investors have bought a total of 18,751 shares in the last 24 months. This purchase volume represents approximately $385.47K in transactions.



This page (NASDAQ:NAMSW) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners